224.92MUSD
See which Billionaires own this investment
Type
Common Stock
Exchange
NASDAQ
Currency Code
USD
Currency Name
US Dollar
Country Name
USA
Country ISO
US
ISIN
CH0329023102
CUSIP
H00263105
Sector
Healthcare
Industry
Biotechnology
Fiscal Year End
December
IPO date
-
Updated At
-
PE Ratio
-
PEG Ratio
-
Book Value
1.12
Dividend Share
-
Dividend Yield
-
Earnings Share
-0.58
Wall Street Target Price
10.14
EPS Estimate Current Year
-0.81
EPS Estimate Next Year
-0.72
EPS Estimate Current Quarter
-0.1903
EPS Estimate Next Quarter
0
Most Recent Quarter
-
Revenue TTM
27,309,000
Gross Profit TTM
-35,261,000
EBITDA
-50,893,000
Profit Margin
-186.44%
Return On Assets TTM
-15.83%
Return On Equity TTM
-37.31%
Revenue Per Share TTM
0.274
Qtly Revenue Growth YOY
-92.30%
Diluted Eps TTM
-0.58
Qtly Earnings Growth YOY
0.00%
Trailing PE
0.00
Forward PE
11
Price Sales TTM
8.2361
Price Book MRQ
1.75
Enterprise Value Revenue
1
Enterprise Value EBITDA
0
80.47
0.68%253.54
0.02%155.00
0.00%97.00
-2.29%97.06
-1.75%262.59
-1.52%190.32
-1.26%613.04
-1.11%665.00
-1.07%511.50
-0.12%